Stryker Corp Stock Forecast for 2023 - 2025 - 2030

Updated on 02/05/2023

Stock Rating
10
Price Target
$260.00
Consensus
Outperform
Downside
-8.17%
Analysts
4
Stock Rating
10
Downside
-8.17%
Analysts
4
Price Target
$260.00

Stryker Corp Stock Forecast and Price Target

Based on the current earnings figures, this year's price targets for Stryker Corp were recently set by four distinguished experts, with an average mark of $260.00. If it reached this goal, it would represent a potential downside of approximately -8.17% from the previous closing price in February, 2023. The high end is $284.00, and the low is $200.00. Even if you're not interested in SYK stock, you may be interested in its competitors.

$260.00

-8.17% Downside

Outperform
Outperform

Stryker Corp Fair Value Forecast for 2023 - 2025 - 2030

In the last two years, Stryker Corp's Price has seen an increase, rising from $212.28 to $233.61. This represents a growth of 10.05%. Analysts predict that Stryker Corp's Fair Value will increase in the upcoming year, reaching $280.90. This would represent an increase of 20.24%. Over the next eight years, experts predict that Stryker Corp's Fair Value will grow at a rate of 53.55%.

2023 Fair Value Forecast
$280.90
2024 Fair Value Forecast
$307.89
2025 Fair Value Forecast
$341.04
2026 Fair Value Forecast
$369.31
2027 Fair Value Forecast
$385.50
2028 Fair Value Forecast
$357.78
2029 Fair Value Forecast
$352.89
2030 Fair Value Forecast
$358.70
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
EW Stock Forecast Edwards Lifesciences Outperform 15
$82.12 $92.45 13.25%
ZBH Stock Forecast Zimmer Biomet Holdings Hold 15
$129.45 $130.09 0.42%
MSA Stock Forecast MSA Safety Outperform 18
$140.35 $145.50 14.71%
IART Stock Forecast Integra LifeSciences Holdings Hold 16
$59.61 $71.75 0.65%
ENOV Stock Forecast Enovis Outperform 15
$65.25 $99.75 8.05%

Stryker Corp Revenue Forecast for 2023 - 2025 - 2030

In the last two years, Stryker Corp's Revenue has seen an increase, rising from $14.88B to $17.11B. This represents a growth of 14.94%. Analysts predict that Stryker Corp's Revenue will increase in the upcoming year, reaching $19.62B. This would represent an increase of 14.69%. Over the next eight years, experts predict that Stryker Corp's Revenue will grow at a rate of 37.62%.

2023 Rev Forecast
$19.62B
2024 Rev Forecast
$20.93B
2025 Rev Forecast
$22.47B
2026 Rev Forecast
$24.00B
2027 Rev Forecast
$25.14B
2028 Rev Forecast
$23.65B
2029 Rev Forecast
$23.29B
2030 Rev Forecast
$23.54B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
CYRX Stock Forecast Cryoport Buy 8
$25.24 $78.50 106.02%
AVNS Stock Forecast Avanos Medical Hold 11
$31.59 $43.00 9.21%
KIDS Stock Forecast OrthoPediatrics Outperform 7
$48.62 $0.00 43.97%

Stryker Corp Dividend per Share Forecast for 2023 - 2025 - 2030

Stryker Corp's Dividend per Share has seen growth In the last two years, going from $2.14 to $2.59 – a gain of 21.03% In the next year, analysts believe that Dividend per Share will reach $3.07 – an increase of 18.53%. For the next eight years, the forecast is forDividend per Share to grow by 44.20%.

2023 DPS Forecast
$3.07
2024 DPS Forecast
$3.43
2025 DPS Forecast
$3.64
2026 DPS Forecast
$3.98
2027 DPS Forecast
$3.65
2028 DPS Forecast
$3.59
2029 DPS Forecast
$3.61
2030 DPS Forecast
$3.73
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
XENT Stock Forecast Intersect ENT - 6
$28.24 $23.50 10.84%
AORT Stock Forecast Artivion Outperform 12
$14.03 $29.15 113.83%
ATEC Stock Forecast Alphatec Holdings Buy 7
$13.48 $0.00 40.95%

Stryker Corp Free Cash Flow Forecast for 2023 - 2025 - 2030

Stryker Corp's Free Cash Flow has grown in the last two years, jumping from $1.54B to $2.74B – an increase of 77.56%. In the next year, analysts predict that Free Cash Flow will reach $3.59B – an increase of 30.99%. For the next eight years, the forecast is for Free Cash Flow to grow by 59.72%.

2023 FCF Forecast
$3.59B
2024 FCF Forecast
$3.73B
2025 FCF Forecast
$3.68B
2026 FCF Forecast
$3.94B
2027 FCF Forecast
$5.42B
2028 FCF Forecast
$4.83B
2029 FCF Forecast
$4.48B
2030 FCF Forecast
$4.37B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
SIBN Stock Forecast SI-BONE Buy 6
$18.32 $0.00 74.67%
AXGN Stock Forecast AxoGen Outperform 6
$9.29 $20.00 115.29%
IIN Stock Forecast IntriCon Buy 10
$24.24 $28.50 3.14%

Stryker Corp Net Income Forecast for 2023 - 2025 - 2030

In the last two years, Stryker Corp's Net Income has seen a drop from $2.08B to $1.99B – a 4.27% decrease. In the coming year, analysts are expecting an increase in Net Income, predicting it will reach $4.17B – an increase of 109.24%. Over the next eight years, experts anticipate that Net Income growth for Stryker Corp will be 165.98%.

2023 NI Forecast
$4.17B
2024 NI Forecast
$4.59B
2025 NI Forecast
$5.08B
2026 NI Forecast
$5.44B
2027 NI Forecast
$5.67B
2028 NI Forecast
$5.29B
2029 NI Forecast
$5.23B
2030 NI Forecast
$5.30B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
SMTI Stock Forecast Sanara MedTech Buy 11
$43.91 $0.00 2.48%
SPNE Stock Forecast SeaSpine Holdings Buy 8
$9.54 $28.61 120.13%
UEEC Stock Forecast United Health Products - 2
$0.25 $0.00 128.00%

Stryker Corp EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, Stryker Corp's EBITDA has increased by 11.50%, going from $4.17B to $4.65B. In the next year, analysts are expecting an increase in EBITDA, predicting it will reach $5.60B – an increase of 20.62%. The Stryker Corp forecast is for EBITDA to reach $6.74B or grow by 45.11%.

2023 EBITDA Forecast
$5.60B
2024 EBITDA Forecast
$6.05B
2025 EBITDA Forecast
$6.75B
2026 EBITDA Forecast
$7.40B
2027 EBITDA Forecast
$6.10B
2028 EBITDA Forecast
$6.14B
2029 EBITDA Forecast
$6.38B
2030 EBITDA Forecast
$6.74B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
LAKE Stock Forecast Lakeland Industries Buy 16
$14.49 $28.00 93.24%
SIEN Stock Forecast Sientra Buy 6
$1.80 $7.67 205.56%
HCMC Stock Forecast Healthier Choices Management - 0
$0.00 $0.00 0.00%

Stryker Corp EBIT Forecast for 2023 - 2025 - 2030

In the last two years, Stryker Corp's EBIT has grown, increasing from $3.39B to $3.66B – an increase of 7.88%. For next year, the 21 analysts predict EBIT of $5.19B, which would mean an increase of 41.90%. Over the next eight years, the pros' prediction is EBITof $6.53B, which would mean a eight-year growth forecast of 78.67%.

2023 EBIT Forecast
$5.19B
2024 EBIT Forecast
$5.64B
2025 EBIT Forecast
$6.24B
2026 EBIT Forecast
$6.87B
2027 EBIT Forecast
$6.81B
2028 EBIT Forecast
$6.41B
2029 EBIT Forecast
$6.36B
2030 EBIT Forecast
$6.53B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
CFMS Stock Forecast Conformis Outperform 0
$0.60 $2.33 233.33%
IVC Stock Forecast Invacare Outperform 12
$1.31 $5.08 358.02%
SRGA Stock Forecast Surgalign Holdings Outperform 8
$3.26 $3.36 820.25%

Stryker Corp EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last two years, Stryker Corp's EPS has seen an increase, rising from $8.26 to $9.09. This represents a growth of 10.05%. Analysts predict that Stryker Corp's EPS will increase in the upcoming year, reaching $10.93. This would represent an increase of 20.24%. Over the next eight years, experts predict that Stryker Corp's EPS will grow at a rate of 53.55%.

2023 EPS Forecast
$10.93
2024 EPS Forecast
$11.98
2025 EPS Forecast
$13.27
2026 EPS Forecast
$14.37
2027 EPS Forecast
$15.00
2028 EPS Forecast
$13.92
2029 EPS Forecast
$13.73
2030 EPS Forecast
$13.96
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
PETV Stock Forecast PetVivo Holdings Buy 0
$2.35 $0.00 197.87%
RMTI Stock Forecast Rockwell Medical Buy 7
$1.33 $3.00 275.94%
SINT Stock Forecast Sintx Technologies Buy 10
$0.46 $2.63 308.70%